Abuse liability of transdermal nicotine patch: a case of "nicotine buzz"

Abhinav Panwar,Samir Kumar Praharaj
DOI: https://doi.org/10.1080/14659891.2024.2347375
2024-04-30
Journal of Substance Use
Abstract:Background Transdermal nicotine patches are widely used for the treatment of nicotine dependence. The abuse liability of nicotine replacement therapies is considered low because of an absence of peaks observed with smoking. While typically well-tolerated, higher doses of transdermal nicotine patches may pose risks of adverse effects, as illustrated by a case of a young adult experiencing euphoria with a 63 mg patch.
substance abuse
What problem does this paper attempt to address?